Driehaus Capital Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Driehaus Capital Management’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-408,553	Closed	-$10.7M	–	576
2019 Q1	$10.7M	Sell	408,553 -599,448	-59%	-$11.2M	0.4%	67
2018 Q4	$11.9M	Buy	1,008,001 +191,020	+23%	+$2.38M	0.51%	51
2018 Q3	$9.11M	Sell	816,981 -6,898	-0.8%	-$72.6K	0.28%	114
2018 Q2	$10.8M	Sell	823,879 -39,904	-5%	-$646K	0.37%	85
2018 Q1	$13.1M	Buy	863,783 +1,504	+0.2%	+$24.5K	0.46%	45
2017 Q4	$16.4M	Buy	862,279 +42,771	+5%	+$716K	0.62%	33
2017 Q3	$13.8M	Buy	+819,508	New	+$13.4M	0.54%	36

Driehaus Capital Management's CMTA Position: Q2 2019 in Review

Driehaus Capital Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 408,553 shares — an estimated $10.7M sold.

Driehaus Capital Management first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $16.4M in Q4 2017. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Driehaus Capital Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Driehaus Capital Management sold 408,553 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $10.7M.
Driehaus Capital Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
Driehaus Capital Management's Clementia Pharmaceuticals Inc. position peaked at $16.4M in Q4 2017.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Driehaus Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.